ArticleUpdates in surgery2025
The effect of receptor for advanced glycation end products (RAGE) expression on the occurrence, development, and prognosis of gastric cancer.
Article in Updates in surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Microsatellite instability and immunotherapy: redefining the role of surgery in colorectal cancer.Updates in surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
We conducted this study to determine whether the receptor for advanced glycation end products (RAGE) expression has an effect on the occurrence, development, and prognosis of gastric cancer (GC).We conducted a systematic search in three databases (PubMed, Embase, and the Cochrane Library) to identify clinical articles that examined RAGE expression in GC. The association between RAGE and clinical characteristics associated with GC was estimated using odds ratios (ORs) and associated 95% confidence intervals (CIs). The registration ID of this current study on PROSPERO is CRD42024547708.We included a total of 2834 patients from nine studies in the current study. After pooling up all the data, we found that RAGE expression was higher in GC than in normal tissues (OR = 6.21, I
Indexed as
Identifiers
40976803What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.